Teijin Total Liabilities 2010-2024 | TINLY
Teijin total liabilities from 2010 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
Teijin Annual Total Liabilities
(Millions of US $) |
| 2024 |
$5,307 |
| 2023 |
$5,856 |
| 2022 |
$6,611 |
| 2021 |
$5,717 |
| 2020 |
$5,454 |
| 2019 |
$5,341 |
| 2018 |
$5,202 |
| 2017 |
$5,632 |
| 2016 |
$4,517 |
| 2015 |
$4,328 |
| 2014 |
$4,683 |
| 2013 |
$5,000 |
| 2012 |
$5,474 |
| 2011 |
$5,310 |
| 2010 |
$5,700 |
Teijin Quarterly Total Liabilities
(Millions of US $) |
| 2024-06-30 |
$5,347 |
| 2023-06-30 |
$6,070 |
| 2022-06-30 |
$6,047 |
| 2021-06-30 |
$6,750 |
| 2020-06-30 |
$5,469 |
| 2019-06-30 |
$5,332 |
| 2018-06-30 |
$5,563 |
| 2017-06-30 |
$5,370 |
| 2016-06-30 |
$4,515 |
| 2015-06-30 |
$4,069 |
| 2015-03-31 |
$4,328 |
| 2014-12-31 |
$4,744 |
| 2014-09-30 |
$4,793 |
| 2014-06-30 |
$4,741 |
| 2014-03-31 |
$4,683 |
| 2013-12-31 |
$4,893 |
| 2013-09-30 |
$4,760 |
| 2013-06-30 |
$4,938 |
| 2013-03-31 |
$5,000 |
| 2012-12-31 |
$5,725 |
| 2012-09-30 |
$5,499 |
| 2012-06-30 |
$5,503 |
| 2012-03-31 |
$5,474 |
| 2011-12-31 |
$6,060 |
| 2011-09-30 |
$6,117 |
| 2011-06-30 |
$5,760 |
| 2011-03-31 |
$5,310 |
| 2010-12-31 |
$5,884 |
| 2010-09-30 |
$5,645 |
| 2010-06-30 |
$5,557 |
| 2010-03-31 |
$5,700 |
| 2009-12-31 |
$6,413 |
| 2009-09-30 |
$5,934 |
| 2009-06-30 |
$5,718 |
| Sector |
Industry |
Market Cap |
Revenue |
| Consumer Discretionary |
Textile - Apparel Manufacturing |
$1.638B |
$7.154B |
|
Teijin Limited is involved in the manufacture, processing and sale of chemical products. Advanced Fibers & Composites segment is engaged in the manufacture and sale of aramid fiber (such as yarn, cotton, woven or knitted fabric), carbon fiber products and polyester fiber (industrial materials). Electric Materials & Chemical Products segment involves in the manufacture and sale of films, resins and resin products. Healthcare segment involves in the manufacture and sale of pharmaceuticals and home medical care equipment, as well as the clinical development of new drugs. Products Converting segment involves in the planning, processing and sale of textile products. Others segment involves in the operation, development and maintenance of information systems, as well as the provision of printing services.
|
